Eli Lilly Names Joshua Smiley CFO
September 29 2017 - 8:41AM
Dow Jones News
By Austen Hufford
Eli Lilly & Co. named a new finance chief and announced a
number of other executive changes, as the drugmaker contends with
layoffs and patent expirations.
The company said Friday that Joshua Smiley would be its next
CFO, promoting an insider into the role. Mr. Smiley, who has been
with the company for more than 20 years, was previously treasurer
and senior vice president of finance. He will begin his new role
Jan. 1. The Indianapolis drugmaker said in June that longtime CFO
Derica Rice would retire at the end of the year after more than a
decade in the position.
The company also appointed new senior leaders overseeing science
and technology and manufacturing operations, who will report to
Chief Executive David Ricks.
Dr. Dan Skovronsky has been promoted to senior vice president
for science and technology and president of Lilly Research Labs.
Myles O'Neill is becoming senior vice president and president of
manufacturing operations. The appointments follow the retirements
of Maria Crowe, president of manufacturing operations, and science
and technology leader Dr. Jan Lundberg.
Earlier this month the company said it would cut roughly 8% of
its global workforce, citing the need to lower costs and raise
investment ahead of patent expirations.
Messrs. Smiley, Skovronsky and O'Neill and Aarti Shah, Eli
Lilly's chief information officer, will join the company's
executive committee.
Write to Austen Hufford at austen.hufford@wsj.com
(END) Dow Jones Newswires
September 29, 2017 08:26 ET (12:26 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Sep 2023 to Sep 2024